Closed ATM View - Health/20-21/RFI
COVID-19 vaccine and treatment manufacture and supply chain RFI
Canberra, Sydney, Melbourne, Adelaide, Perth, Brisbane, Darwin, Hobart
In response to the COVID-19 pandemic, the Australian Government is working to seek early access to and delivery of safe and effective COVID-19 vaccines and treatments as soon as they are available.
The Government is conducting an audit of onshore capacity and capability to complement existing information and help inform possible COVID-19 vaccine and treatment manufacturing scenarios.
The RFI is seeking information from organisations already regulated or likely to seek regulation through the Therapeutic Goods Administration. It is intended to inform decision making and identify those opportunities which can feasibly be explored to support COVID-19 vaccine and treatments manufacture.
This RFI seeks information regarding COVID-19 vaccine and treatment manufacture and supply, in particular, manufacturer current capability and capacity, as well as manufacturer willingness to expand, modify or repurpose capability and capacity to support at population-scale the manufacture of COVID-19 vaccines and treatments.
This RFI does not include a request for information on activity which is at R&D stage or could not satisfy population-scale, commercial supply and regulation demands.
Respondents should use the template provided in response to the RFI.
Not Applicable
Not Applicable
www.tenders.gov.au